Condition: Neovascular Age-Related Macular Degeneration (nAMD) · Sponsor: AbbVie
This is a prospective study designed to evaluate the long-term safety and efficacy of ABBV-RGX-314. Eligible participants are those who were previously enrolled in a clinical study of nAMD in which they received suprachoroidal space (SCS) administration of ABBV-RGX-314. Enrollment of each participant in the current study should occur after the participant has completed either the end of study or early discontinuation visit in the previous (parent) clinical study. Participants will be followed for up to 5 years after ABBV-RGX-314 administration (inclusive of the parent study). As such, the total study duration for each participant may vary depending on when they enroll in the current study following ABBV-RGX-314 administration in the parent study.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Retinal Research Institute, LLC | Phoenix, Arizona, United States | — |
| California Retina Consultants | Bakersfield, California, United States | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills, California, United States | — |
| Northern California Retina Vitreous Associates Medical Group Inc | Mountain View, California, United States | — |
| Retina Consultants San Diego | Poway, California, United States | — |
| California Retina Consultants | Santa Barbara, California, United States | — |
| Southeast Retina Center PC | Augusta, Georgia, United States | — |
| Johns Hopkins University | Baltimore, Maryland, United States | — |
| Ophthalmic Consultants of Boston | Boston, Massachusetts, United States | — |
| Vitreoretinal Surgery PLLC | Edina, Minnesota, United States | — |
| Sierra eye Associates | Reno, Nevada, United States | — |
| Vision Research Center Eye Associates of New Mexico | Albuquerque, New Mexico, United States | — |
+ 4 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.